Internal and Supplier Audits Led by Former Regulators and Industry Experts
Effective audit programs require more than checklist reviews. Organizations benefit most from audits conducted by professionals who understand how regulators assess risk, interpret data, and evaluate quality systems during real inspections.
At BioBoston Consulting, internal and supplier audits are led by former regulators and experienced industry specialists who bring practical inspection insight and operational expertise. Our approach focuses on identifying risks early, strengthening quality systems, and ensuring alignment with global regulatory expectations.
Our audit approach includes:
-
Comprehensive internal audits evaluating QMS effectiveness, documentation practices, and operational controls
-
Supplier and vendor audits assessing GMP compliance, quality oversight, and contractual alignment
-
Risk-based evaluation aligned with program stage and regulatory milestones
-
Detailed findings supported by practical, prioritized remediation recommendations
-
Clear documentation designed to support inspection readiness
Value for organizations:
-
Early identification of compliance gaps before regulatory inspections
-
Stronger oversight of third-party manufacturers, CROs, and critical suppliers
-
Improved traceability and documentation integrity
-
Enhanced confidence in inspection preparedness and regulatory compliance
By combining regulatory inspection experience with industry operational knowledge, we help organizations move beyond compliance verification toward proactive risk management and sustained quality performance.
Audits informed by regulatory behavior
BioBoston Consulting audit teams include former FDA investigators and senior quality leaders with extensive experience supporting and leading regulatory inspections. This background shapes how our audits are planned, executed, and reported.
Our audit services include:
- Independent internal audits that objectively assess GxP processes, systems, and controls
- Supplier audits focused on material impact, data integrity, and quality agreement execution
- Inspection-aligned audits reflecting FDA and global health authority questioning techniques
- Data integrity audits aligned with ALCOA+ principles and regulatory guidance
- Risk-based audit scoping, tailored to product lifecycle stage and regulatory exposure
This approach helps organizations identify gaps that internal teams may overlook.
What our audits evaluate in practice
Our audits go beyond surface level compliance. We assess how quality systems perform under real conditions, including:
- Effectiveness of training and role execution
- Consistency of deviation, CAPA, and change control processes
- Oversight of contract manufacturers, laboratories, and critical suppliers
- Governance, escalation, and management involvement in quality decisions
Findings are clearly linked to inspection risk, enabling leadership teams to prioritize remediation with confidence.
Practical outcomes that strengthen readiness
Organizations engaging BioBoston Consulting for independent audits gain:
- Objective, regulator-informed insight into GxP compliance
- Risk-ranked audit observations with clear regulatory context
- Stronger alignment between internal audits, supplier audits, and inspection readiness
- Improved confidence ahead of FDA and global health authority inspections
Our audits are designed to support sustainable compliance, not one-time readiness exercises.
If your audit program would benefit from an independent, regulator-informed perspective, BioBoston Consulting can help.
Connect with us to conduct internal and supplier audits led by former regulators and industry experts designed to strengthen compliance and reduce inspection risk.